menu search

Fda approves syfovre™ (pegcetacoplan injection) as the first and only treatment for geographic atrophy (ga), a leading cause of blindness

SYFOVRE slowed GA progression with increasing effects over time approved for all patients with GA, with...

February 17, 2023, 9:06 pm

Financial institutions, inc. announces 3.4% increase in common stock dividend

13th Consecutive Annual Increase WARSAW, N.Y., Feb. 17, 2023 (GLOBE NEWSWIRE) — Financial Institutions, Inc. (NASDAQ: FISI) (the “Company”), par...

February 17, 2023, 9:05 pm

Black swan graphene updates investors on corporate developments

Black Swan Graphene (TSX-V:SWAN) Inc told investors that its shareholders have approved its previously...

February 17, 2023, 3:46 pm

Beat the dow jones with crispr therapeutics stock

If approved, CRISPR's first product may deliver blockbuster sales....

February 17, 2023, 2:00 pm

Adient: nio and toyota agreements positive, but risks persist

Adient is a company dedicated to the manufacture and sale of automotive elements, mainly high-comfort seats that are integrated with high-tech comfort...

February 16, 2023, 11:08 pm

Mimi’s rock corp. shareholders approve acquisition by fitlife brands

Transformative acquisition will double the size of FitLife with minimal leverage and no dilution to shareholders OMAHA, NE, Feb. 16, 2023 (GLOBE NEWSW...

February 16, 2023, 10:09 pm

Meritage homes initiates quarterly cash dividend

SCOTTSDALE, Ariz., Feb. 16, 2023 (GLOBE NEWSWIRE) — Meritage Homes Corporation (NYSE: MTH), the fifth-largest homebuilder in the U.S., today announc...

February 16, 2023, 10:00 pm

Gns stock alert: what to know as genius group plans share buyback

Genius Group (NYSEMKT: GNS ) stock is on the move Thursday as investors approve a share buyback plan. T...

February 16, 2023, 9:05 am

Algernon pharma says unit completes dosing of first cohort in its phase 1 clinical study of an intravenous formulation of dmt

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Neuro), has completed dosing of the first cohort i...

February 16, 2023, 7:59 am

Humana raises quarterly dividend by 12.4% to 88.50 cents a share

Healthcare provider Humana Inc. HUM, -0.67% said Thursday its board has approved a 12.4% increase in it...

February 16, 2023, 6:34 am

Apple to scrutinize customer history for ‘pay later' service

Bloomberg's Mark Gurman joins Caroline Hyde and Ed Ludlow to discuss Apple's push into the lending business with a “buy now, pay later” service, w...

February 15, 2023, 7:10 pm

Twilio stock jumps 12% after chasing layoffs with first major share-repurchase plan

Twilio Inc. TWLO, +6.36% announced its first major share-repurchase plan Wednesday, two days after revealing the second large round of layoffs at the ...

February 15, 2023, 4:45 pm

Mckesson (mck) announces availability of fda-cleared drug for mcl

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for ...

February 15, 2023, 10:32 am

Canada silver cobalt works readies coniagas battery metals spin-out

Canada Silver Cobalt Works Inc (TSX-V:CCW, OTCQB:CCWOF) told investors that the planned spin-out of its subsidiary Coniagas Battery Metals Inc has now...

February 15, 2023, 10:11 am

Next round of financing will be transformational for ocular therapeutix

Ocular Therapeutix is a promising platform play poised to disruptively transform ophthalmology. Based on its innovative and validated hydrogel platfor...

February 14, 2023, 9:01 am

Altria: stock chart and fundamentals suggest it is currently undervalued

The company projects a growth rate of 3-6% for 2023 and recently approved a $1 billion share repurchase...

February 14, 2023, 8:31 am

Tsmc to boost capital at arizona factory by $3.5 bln

Taiwanese chipmaker TSMC said on Tuesday its board had approved a plan to boost the capital of its chip...

February 14, 2023, 6:34 am

Pharmadrug unveils plans for first-in-human clinical study with its lead drug candidate pd-001 in esophageal cancer

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) revealed that it intends to pursue a first-in-human study of its lead drug candidate cepharanthine-2HCL (PD-001...

February 13, 2023, 9:11 am

Evergold receives drill permit for its rockland gold-silver property in nevada

Evergold Corp (TSX-V:EVER, OTC:EVGUF) announced that a detailed plan of operations has been approved, a...

February 13, 2023, 8:47 am

Polarean imaging looking to gain commercial traction for its xenoview

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) is looking to gain "commercial traction" for its medical imaging product, XENOVIEW, the first and only FDA-...

February 13, 2023, 2:57 am


Search within

Pages Search Results: